Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fractyl Health (GUTS) Cash from Operations (2023 - 2025)

Fractyl Health (GUTS) has disclosed Cash from Operations for 3 consecutive years, with 22714000.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Cash from Operations fell 25.92% year-over-year to 22714000.0, compared with a TTM value of 86026000.0 through Sep 2025, down 45.59%, and an annual FY2024 reading of 65521000.0, down 53.0% over the prior year.
  • Cash from Operations was 22714000.0 for Q3 2025 at Fractyl Health, down from 21199000.0 in the prior quarter.
  • Across five years, Cash from Operations topped out at 9550000.0 in Q1 2023 and bottomed at 25079000.0 in Q1 2025.
  • Average Cash from Operations over 3 years is 16121454.55, with a median of 17034000.0 recorded in 2024.
  • Peak annual rise in Cash from Operations hit 13.14% in 2025, while the deepest fall reached 114.15% in 2025.
  • Year by year, Cash from Operations stood at 10599000.0 in 2023, then tumbled by 60.71% to 17034000.0 in 2024, then plummeted by 33.35% to 22714000.0 in 2025.
  • Business Quant data shows Cash from Operations for GUTS at 22714000.0 in Q3 2025, 21199000.0 in Q2 2025, and 25079000.0 in Q1 2025.